Healthcare & Pharmaceuticals

McKesson begins distribution of Johnson & Johnson's COVID-19 vaccine

2 minute read

Vials labelled "COVID-19 Coronavirus Vaccine" and syringe are seen in front of displayed Johnson & Johnson logo in this illustration taken, February 9, 2021. REUTERS/Dado Ruvic/Illustration

March 1 (Reuters) - U.S. drug distributor McKesson Corp (MCK.N) said on Monday it had begun distribution of Johnson & Johnson's (JNJ.N) COVID-19 vaccine.

The vaccine became the third authorized COVID-19 vaccine in the United States over the weekend, following Friday's unanimous endorsement by the Food and Drug Administration's panel of outside experts. read more

McKesson is the partner for the U.S. government's COVID-19 vaccine distribution and the company has established four distribution centers which will be specifically used to distribute the Johnson & Johnson COVID-19 vaccine.

The U.S. government makes the administration decisions, including where, when and how many vaccine doses McKesson will distribute, the company said.

Initial deliveries of the vaccine should begin on Tuesday, senior Biden administration officials had said on Sunday. read more

Reporting by Manas Mishra in Bengaluru; Editing by Sriraj Kalluvila

Our Standards: The Thomson Reuters Trust Principles.

More from Reuters